Yin Yang 1 promotes hepatic gluconeogenesis through upregulation of glucocorticoid receptor

Diabetes

Volumn 62, Issue 4, 2013, Pages 1064-1073

  Lu, Yan ^a   Xiong, Xuelian ^a   Wang, Xiaolin ^a   Zhang, Zhijian ^a   Li, Jin ^a   Shi, Guojun ^a   Yang, Jian ^a   Zhang, Huijie ^a   Ning, Guang ^a,b   Li, Xiaoying ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b E Institutes of Shanghai Universities   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; GLUCOSE; MESSENGER RNA; TRANSCRIPTION FACTOR YY1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HEPATIC GLUCONEOGENESIS; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIVER METABOLISM; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; BLOOD GLUCOSE; CELL LINE; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FOOD DEPRIVATION; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; LIVER; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, TRANSGENIC; NUCLEAR RECEPTOR COACTIVATOR 1; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; UP-REGULATION; YY1 TRANSCRIPTION FACTOR;

EID: 84875472538     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0744     Document Type: Article

References (42)

1. Granner DK, O'Brien RM. Molecular physiology and genetics of NIDDM. Importance of metabolic staging. Diabetes Care 1992;15:369-395
2. Hall RK, Granner DK. Insulin regulates expression of metabolic genes through divergent signaling pathways. J Basic Clin Physiol Pharmacol 1999;10:119-133
3. Cao H, van der Veer E, Ban MR, et al. Promoter polymorphism in PCK1 (phosphoenolpyruvate carboxykinase gene) associated with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004;89:898-903
4. Gómez-Valadés AG, Méndez-Lucas A, Vidal-Alabró A, et al. Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice. Diabetes 2008;57:2199-2210
5. Pilkis SJ, el-Maghrabi MR, Claus TH. Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Biochem 1988;57:755-783
6. Koo SH, Flechner L, Qi L, et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005;437:1109-1111
7. Altarejos JY, Montminy M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 2011;12:141-151
8. van Schaftingen E, Gerin I. The glucose-6-phosphatase system. Biochem J 2002;362:513-532
9. Hanson RW, Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 1997;66:581-611
10. Lee MW, Chanda D, Yang J, et al. Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. Cell Metab 2010;11:331-339
11. Liu Y, Nakagawa Y, Wang Y, et al. Increased glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Diabetes 2005;54:32-40
12. Watts LM, Manchem VP, Leedom TA, et al. Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism. Diabetes 2005;54: 1846-1853
13. Thomas MJ, Seto E. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 1999;236:197-208
14. Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 2006;25:1125-1142
15. Donohoe ME, Zhang X, McGinnis L, Biggers J, Li E, Shi Y. Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. Mol Cell Biol 1999;19:7237-7244
16. Castellano G, Torrisi E, Ligresti G, et al. The involvement of the transcription factor Yin Yang 1 in cancer development and progression. Cell Cycle 2009;8:1367-1372
17. Huang HY, Li X, Liu M, et al. Transcription factor YY1 promotes adipogenesis via inhibiting CHOP-10 expression. Biochem Biophys Res Commun 2008;375:496-500
18. Blättler SM, Cunningham JT, Verdeguer F, et al. Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling. Cell Metab 2012;15: 505-517
19. Logsdon BA, Hoffman GE, Mezey JG. Mouse obesity network reconstruction with a variational Bayes algorithm to employ aggressive false positive control. BMC Bioinformatics 2012;13:53
20. Lemke U, Krones-Herzig A, Berriel Diaz M, et al. The glucocorticoid receptor controls hepatic dyslipidemia through Hes1. Cell Metab 2008;8: 212-223
21. Phuc Le P, Friedman JR, Schug J, et al. Glucocorticoid receptor-dependent gene regulatory networks. PLoS Genet 2005;1:e16
22. Dong Y, Aronsson M, Gustafsson JA, Okret S. The mechanism of cAMPinduced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response. J Biol Chem 1989;264:13679-13683
23. Austen M, Lüscher B, Lüscher-Firzlaff JM. Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding protein. J Biol Chem 1997;272:1709-1717
24. York B, O'Malley BW. Steroid receptor coactivator (SRC) family: masters of systems biology. J Biol Chem 2010;285:38743-38750
25. Breslin MB, Vedeckis WV. The human glucocorticoid receptor promoter upstream sequences contain binding sites for the ubiquitous transcription factor, Yin Yang 1. J Steroid Biochem Mol Biol 1998;67:369-381
26. Nunez BS, Vedeckis WV. Characterization of promoter 1B in the human glucocorticoid receptor gene. Mol Cell Endocrinol 2002;189:191-199
27. Rhee J, Inoue Y, Yoon JC, et al. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci USA 2003;100: 4012-4017
28. Barthel A, Schmoll D, Unterman TG. FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab 2005;16:183-189
29. Kim DH, Perdomo G, Zhang T, et al. FoxO6 integrates insulin signaling with gluconeogenesis in the liver. Diabetes 2011;60:2763-2774
30. Liu NC, Lin WJ, Kim E, et al. Loss of TR4 orphan nuclear receptor reduces phosphoenolpyruvate carboxykinase-mediated gluconeogenesis. Diabetes 2007;56:2901-2909
31. Duclos M, Gatta B, Corcuff JB, Rashedi M, Pehourcq F, Roger P. Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids. Clin Endocrinol (Oxf) 2001;55:447-454
32. Levitt NS, Lambert EV, Woods D, Hales CN, Andrew R, Seckl Jr. Impaired glucose tolerance and elevated blood pressure in low birth weight, nonobese, young south african adults: early programming of cortisol axis. J Clin Endocrinol Metab 2000;85:4611-4618
33. de Oliveira C, de Mattos AB, Biz C, Oyama LM, Ribeiro EB, do Nascimento CM. High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations. Lipids Health Dis 2011; 10:11
34. Opherk C, Tronche F, Kellendonk C, et al. Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus. Mol Endocrinol 2004;18:1346-1353
35. Hudson AR, Roach SL, Higuchi RI. Recent developments in the discovery of selective glucocorticoid receptor modulators (SGRMs). Curr Top Med Chem 2008;8:750-765
36. Liu Y, Yan C, Wang Y, et al. Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice. Endocrinology 2006;147: 5061-5068
37. He CQ, Ding NZ, Fan W. YY1 repressing peroxisome proliferator-activated receptor delta promoter. Mol Cell Biochem 2008;308:247-252
38. Deng Z, Wan M, Cao P, Rao A, Cramer SD, Sui G. Yin Yang 1 regulates the transcriptional activity of androgen receptor. Oncogene 2009;28:3746-3757
39. Shi Y, Lee JS, Galvin KM. Everything you have ever wanted to know about Yin Yang 1... Biochim Biophys Acta 1997;1332:F49-F66
40. He Y, Casaccia-Bonnefil P. The Yin and Yang of YY1 in the nervous system. J Neurochem 2008;106:1493-1502
41. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007;450:736-740
42. Louet JF, Chopra AR, Sagen JV, et al. The coactivator SRC-1 is an essential coordinator of hepatic glucose production. Cell Metab 2010;12:606-618